Anthera announces leadership transition in preparation of commercialization of Sollpura
Anthera Pharmaceuticals' Board of Directors announced J. Craig Thompson has been promoted to CEO. Paul Truex has stepped down from the CEO role and been appointed to the newly created role of Executive Chairman and concurrently, Dr. Christopher Henney has stepped down as Chairman. December 06, 2016